Nifedipine ( DrugBank: Nifedipine )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
50	Dermatomyositis	1
81	Congenital adrenal hyperplasia	1

50. Dermatomyositis

---

Clinical trials : 182 /  Drugs : 229 - (DrugBank : 88) / Drug target genes : 48 - Drug target pathways : 147

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03027674 (ClinicalTrials.gov)	August 2016	13/1/2017	Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud	Color Doppler Ultrasound Comparison of Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud: A Randomized, Double-blind, Placebo-controlled Pilot Study	Raynaud Phenomenon Due to Trauma;Raynaud Disease;System; Sclerosis;Lupus Erythematosus, Systemic;Dermatomyositis;Ultrasound Therapy; Complications	Drug: 10% nifedipine cream;Drug: 5% sildenafil cream	Pontificia Universidad Catolica de Chile	NULL	Completed	13 Years	99 Years	All	10	Early Phase 1	Chile

81. Congenital adrenal hyperplasia

---

Clinical trials : 88 /  Drugs : 90 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00000102 (ClinicalTrials.gov)		3/11/1999	Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets		Congenital Adrenal Hyperplasia	Drug: Nifedipine	National Center for Research Resources (NCRR)	NULL	Completed	14 Years	35 Years	Both		Phase 1/Phase 2	United States